App tracks life with advanced melanoma
NCT ID NCT04911998
Summary
This study observed 400 adults in Europe with advanced, hard-to-treat skin cancer (melanoma) who were already receiving standard targeted drug therapy. The goal was to learn about these patients and understand how they used a specific mobile app (TavieSkin) designed to support them. Researchers collected data through the app on patient backgrounds, quality of life, treatment adherence, and satisfaction with both the app and their medication.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Evora
Evora, Portugal
Conditions
Explore the condition pages connected to this study.